Bill
SD 532
An Act relative to patient access to biomarker testing to provide appropriate therapy
194th Legislature (2025-2026)
Introduced by Mike Brady and 17 co-sponsors
Requires Massachusetts insurers to cover cancer biomarker testing without prior authorization delays to enable personalized therapy selection.